Editorial Guide

Focus Issue: Targeting Signaling Pathways for Drug Discovery

Science's STKE  23 Mar 2004:
Vol. 2004, Issue 225, pp. eg5
DOI: 10.1126/stke.2252004eg5

You are currently viewing the abstract.

View Full Text
As a service to the community, AAAS/Science has made this article free with registration.


This STKE Focus Issue on processes, targets, and opportunities in drug discovery is part of a coordinated effort to cover a broad range of topics related to drug discovery in Science's multiple online products and in a special issue of Science itself. STKE features three Perspectives and one Review that highlight drug development and signaling targets for therapeutic development. Shen describes the production of natural bioactive products by combinatorial biosynthesis in bacteria. Philips describes anticancer therapies aimed at the oncogenic guanosine triphosphatase Ras, and Kaelin discusses whether common cancers are likely to yield to single anticancer agents and echo the rousing success of the kinase inhibitor Gleevec. Charney and Manji discuss how an increased understanding of the underlying pathways could lead to novel potential therapies for treating depression.

View Full Text